| ²é¿´: 2948 | »Ø¸´: 60 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û48´Î£¬×÷ÕßruninwindÔö¼Ó½ð±Ò 43.25 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
[×ÊÔ´]
·ÖÏí¿¹Ö×ÁöÒ©ÎïºÃÊéÒ»±¾<Cancer Drug Design and Discovery>2008¡¾ËÑËØÎÞÖØ¸´¡¿
|
||
|
Stephen Neidle is Professor of Chemical Biology, CRUK Professorial Fellow, and Director of the Centre for Cancer Medicines at the School of Pharmacy, University of London, where he directs a group working on the structure-based design and medicinal chemistry of novel agents targeting telomerase and other cancer-related genes. His work has been recognized by the Medicinal Chemistry and Interdisciplinary Awards of the Royal Society of Chemistry, and the Aventis Award of the French Societ¨¦ de Chimie Th¨¦rapeutique. ¸Õ´ÓSDÉÏÏÂÔØµÄ£¬Óë´ó¼Ò·ÖÏí http://d.namipan.com/d/77342c456aeb1ebcf10b6aff32d0799dffeb91ffa7517f00 |
» ²ÂÄãϲ»¶
²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤£¨085600£©296Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ7È˻ظ´
343Çóµ÷¼Á085601
ÒѾÓÐ3È˻ظ´
08¹¤¿ÆÇóµ÷¼Á286
ÒѾÓÐ3È˻ظ´
337Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
329Çóµ÷¼Á£¬Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ£¬²ÄÁϹ¤³Ì£¨085601£©
ÒѾÓÐ10È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
299Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
ÃæÉÏ5BÄÜÉÏ»áÂð£¿
ÒѾÓÐ4È˻ظ´
14Â¥2009-08-16 14:05:13
8Â¥2009-08-16 09:15:24
11Â¥2009-08-16 10:13:14
¼òµ¥»Ø¸´
tjegg3Â¥
2009-08-15 20:14
»Ø¸´

















»Ø¸´´ËÂ¥
6